Revolutionary fully implanted hearing device tested in adults

NCT ID NCT06699797

Ongoing Disease control Sponsor: Envoy Medical Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a fully implanted cochlear implant called Acclaim CI in 56 adults with severe to profound hearing loss. The goal is to see if it helps them hear words better than before and to check for any medical problems. Participants get the implant and are followed for up to 2 years.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENSORI-NEURAL DEAFNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hearing Loss, Sensorineural sensorineural hearing loss disorder X-linked mixed hearing loss with perilymphatic gusher

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SENSORI-NEURAL DEAFNESS SENSORINEURAL HEARING LOSS SENSORINEURAL HEARING LOSS (DISORDER) SENSORINEURAL HEARING LOSS, BILATERAL SENSORINEURAL HEARING LOSS, PROFOUND SENSORINEURAL HEARING LOSS, SEVERE

Contacts and locations

Show contact details

Locations

Center for Neurosciences Ear and Hearing Center

Tucson, Arizona, 85718, United States
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Hearts for Hearing

Oklahoma City, Oklahoma, 73114, United States
MUSC Health

Charleston, South Carolina, 29425, United States
Mayo Clinic

Rochester, Minnesota, 55902, United States
Shohet Ear Associates

Seal Beach, California, 90740, United States
University of Florida Health

Gainesville, Florida, 32607, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.